Product	Form / Strength	Country	Reg. Number	Status
HERCEPTIN SC 600MG TRASTUZUMAB	TRASTUZUMAB 600MG	Kenya	H2021/CTD8039/16461	Registered
KADCYLA 100 MG TRASTUZUMAB EMTANSINE	ONE VIAL OF POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION CONTAINS 100 MG OF TRASTUZUMAB EMTANSINE. AFTER RECONSTITUTION ONE VIAL OF 5 ML SOLUTION CONTAINS 20 MG/ML OF TRASTUZUMAB EMTANSINE.	Kenya	H2022/CTD9713/21694	Registered
KADCYLA 160 MG TRASTUZUMAB EMTANSINE	ONE VIAL OF POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION CONTAINS 160 MG OF TRASTUZUMAB EMTANSINE. AFTER RECONSTITUTION ONE VIAL OF 8 ML SOLUTION CONTAINS 20 MG/ML OF TRASTUZUMAB EMTANSINE	Kenya	H2022/CTD9715/21695	Registered
Kadcyla trastuzumab emtansine	Solution for injection in vial	Zambia	ZAMRA-HM-26-48	Registered/Compliant
MABTHERA 100 RITUXIMAB	RITUXIMAB	Kenya	16543	Registered
MABTHERA 100 RITUXIMAB	RITUXIMAB	Kenya	H2005/272/16543	Registered
MABTHERA 500 RITUXIMAB	RITUXIMAB 500MG	Kenya	H2005/273	Registered
MIRCERA METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	INJECTABLE; INJECTION 75MCG/0.3ML	Zimbabwe	2014/10.1/4835	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
MIRCERA METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	SOLUTION; INJECTION 100MCG/0.3 ML	Zimbabwe	2014/10.1/4836	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
MIRCERA 120 METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 120MCG	Kenya	H2010/21146/127	Registered
MIRCERA 75 METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 75MCG	Kenya	H2008/19615/411	Registered
MIRCERA INJECTION methoxy polyethylene glycol-epoetin beta	SOLUTION FOR INJECTION	Botswana	BOT1202166	Registered/Compliant
MIRCERA INJECTION -	SOLUTION FOR INJECTION	Botswana	BOT1202167	Registered/Compliant
MIRCERA INJECTION -	SOLUTION FOR INJECTION	Botswana	BOT1202168	Registered/Compliant
MIRCERA INJECTION methoxy polyethylene glycol-epoetin beta	SOLUTION FOR INJECTION	Botswana	BOT1202169	Registered/Compliant
OCREVUS OCRELIZUMAB	EACH 10MLS VIALS CONTAINS 300MG OCRELIZUMAB PH. EUR./USP	Kenya	H2022/CTD9819/21586	Registered
Ocrelizumab Ocrelizumab	Solution For Infusion	Zambia	ZAMRA-HM-24-82	Registered/Compliant
Ocrevus IV Alpha, alpha trehalose dihydate 400.0 mg mg per vial,Glacial Acetic Acid 2.5 mg mg per vial,Ocrelizumab 300 mg mg per vial,Polysorbate 20 2.0 mg mg per vial,Sodium Acetate Trihydrate 21.4 mga mg per vial,Water for injections 10.0 ml ml/vial	Injection 10.0 ml ml/vial,2.0 mg mg per vial,2.5 mg mg per vial,21.4 mga mg per vial,300 mg mg per vial,400.0 mg mg per vial	Zambia	ZAMRA-HM-24-82	Registered/Compliant
PEGASYS 180 PEGINTERFERON ALFA-2A	PEGINTERFERON ALFA-2A 180MCG	Kenya	15120
PERJETA PERTUZUMAB	PERTUZUMAB 42OMG/14ML	Ghana	FDA/BL/233-08012	3 months to expiry

Prev 1 2 3 4 Next

75 products